Cannabis Market By Product Type (Buds or Marijuana Flower, Cannabis Extracts), By Compound (THC-dominant, Balanced THC and CBD, CBD-dominant), By Application (Medical, Recreational, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global cannabis market was valued at $25.7 billion in 2021, and is projected to reach $148.9 billion by 2031, growing at a CAGR of 20.1% from 2022 to 2031.Cannabis is a psychoactive narcotic derived from the Cannabis plant, which is also known by various names, including marijuana. The cannabis plant, which is indigenous to Central and South Asia, has been used for ages in traditional remedies as well as a narcotic for both recreational and entheogenic uses. One of the 483 known plant chemicals, comprising at least 65 more cannabinoids, including cannabidiol, tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis (CBD). Cannabis can be consumed as a smoked product, vaped, ingested, or utilized as an extract. Although it can be used for spiritual objectives, cannabis is most frequently utilized for recreational or therapeutic purposes. Although it is legal in some places, it is the most widely used illegal substance in the world. Adults in Zambia, the U.S., Canada, and Nigeria use it the most frequently.
The global cannabis market is analyzed on the basis of product type, compound, application, and region. By product type, the market is divided into buds or marijuana flower and cannabis extracts. By compound, the market is divided into THC-dominant, balanced THC & CBD, and CBD-dominant. By application, it is classified into medical, recreational, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, Italy, Denmark, Poland, the UK, and the rest of Europe), Asia-Pacific (Thailand, Australia, New Zealand, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and Rest of LAMEA).
The impact of the COVID-19 outbreak was negative on the growth of the global cannabis market. The trade restrictions and lockdown resulted into halting of production and manufacturing units. Conversely, the recovery of the cannabis market is expected in near future.
The legalization of cannabis in many different places, the growing public knowledge of cannabis' health advantages, and its expanding use in medicine to treat a variety of ailments and symptoms are the main reasons driving the expansion of the global cannabis industry. Additionally, the development of new products and increasing R&D operations support the expansion of the cannabis business. Cannabis use is subject to complicated regulations, and the use of cannabis is stigmatized in society, which restricts market expansion. For companies in the cannabis market, however, the legalization of cannabis in Asia-Pacific is anticipated to present attractive development prospects.
The key players operating in the cannabis market have adopted product launch, business expansion, and merger & acquisition as its key strategies to expand their market share, increase profitability, and remain competitive in the market. The major players operating in the global cannabis market are Aurora Cannabis Inc., Tilray, Canopy Growth Corporation, Cresco Labs, Curaleaf, Ecofibre Limited, Green Thumb Industries, Hexo Corporation, INDIVA, Maricann Inc., Medical Marijuana Inc., MME LLC., Organigram Holdings Inc., Stencocare, and Harvest Health & Recreation, Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cannabis market analysis from 2021 to 2031 to identify the prevailing cannabis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cannabis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cannabis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Buds or Marijuana Flower
Cannabis Extracts
By Compound
THC-dominant
Balanced THC and CBD
CBD-dominant
By Application
Medical
Recreational
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
Italy
Denmark
Poland
UK
Rest of Europe
Asia-Pacific
Thailand
Australia
New Zealand
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Rest of LAMEA
Key Market Players
Aurora Cannabis Inc.
Tilray
Canopy Growth Corporation
Cresco Labs
Curaleaf
Ecofibre Limited
Green Thumb Industries
HEXO Corp.
INDIVA
Maricann Inc.
medical marijuana inc.
MME, LLC.
Organigram Holdings Inc.
Stenocare
Harvest Health & Recreation, Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Value Chain Analysis
- 3.8.Market Share Analysis
- CHAPTER 4: CANNABIS MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Buds or Marijuana Flower
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Cannabis Extracts
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: CANNABIS MARKET, BY COMPOUND
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 THC-dominant
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Balanced THC and CBD
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 CBD-dominant
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: CANNABIS MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Medical
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Recreational
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: CANNABIS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Compound
- 7.2.4 North America Market size and forecast, by Application
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product Type
- 7.2.5.1.2 Market size and forecast, by Compound
- 7.2.5.1.3 Market size and forecast, by Application
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product Type
- 7.2.5.2.2 Market size and forecast, by Compound
- 7.2.5.2.3 Market size and forecast, by Application
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product Type
- 7.2.5.3.2 Market size and forecast, by Compound
- 7.2.5.3.3 Market size and forecast, by Application
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Compound
- 7.3.4 Europe Market size and forecast, by Application
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product Type
- 7.3.5.1.2 Market size and forecast, by Compound
- 7.3.5.1.3 Market size and forecast, by Application
- 7.3.5.2 Italy
- 7.3.5.2.1 Market size and forecast, by Product Type
- 7.3.5.2.2 Market size and forecast, by Compound
- 7.3.5.2.3 Market size and forecast, by Application
- 7.3.5.3 Denmark
- 7.3.5.3.1 Market size and forecast, by Product Type
- 7.3.5.3.2 Market size and forecast, by Compound
- 7.3.5.3.3 Market size and forecast, by Application
- 7.3.5.4 Poland
- 7.3.5.4.1 Market size and forecast, by Product Type
- 7.3.5.4.2 Market size and forecast, by Compound
- 7.3.5.4.3 Market size and forecast, by Application
- 7.3.5.5 UK
- 7.3.5.5.1 Market size and forecast, by Product Type
- 7.3.5.5.2 Market size and forecast, by Compound
- 7.3.5.5.3 Market size and forecast, by Application
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product Type
- 7.3.5.6.2 Market size and forecast, by Compound
- 7.3.5.6.3 Market size and forecast, by Application
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Compound
- 7.4.4 Asia-Pacific Market size and forecast, by Application
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Thailand
- 7.4.5.1.1 Market size and forecast, by Product Type
- 7.4.5.1.2 Market size and forecast, by Compound
- 7.4.5.1.3 Market size and forecast, by Application
- 7.4.5.2 Australia
- 7.4.5.2.1 Market size and forecast, by Product Type
- 7.4.5.2.2 Market size and forecast, by Compound
- 7.4.5.2.3 Market size and forecast, by Application
- 7.4.5.3 New Zealand
- 7.4.5.3.1 Market size and forecast, by Product Type
- 7.4.5.3.2 Market size and forecast, by Compound
- 7.4.5.3.3 Market size and forecast, by Application
- 7.4.5.4 Rest of Asia-Pacific
- 7.4.5.4.1 Market size and forecast, by Product Type
- 7.4.5.4.2 Market size and forecast, by Compound
- 7.4.5.4.3 Market size and forecast, by Application
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Compound
- 7.5.4 LAMEA Market size and forecast, by Application
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product Type
- 7.5.5.1.2 Market size and forecast, by Compound
- 7.5.5.1.3 Market size and forecast, by Application
- 7.5.5.2 South Africa
- 7.5.5.2.1 Market size and forecast, by Product Type
- 7.5.5.2.2 Market size and forecast, by Compound
- 7.5.5.2.3 Market size and forecast, by Application
- 7.5.5.3 Rest of LAMEA
- 7.5.5.3.1 Market size and forecast, by Product Type
- 7.5.5.3.2 Market size and forecast, by Compound
- 7.5.5.3.3 Market size and forecast, by Application
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Aurora Cannabis Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Aphria Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Canopy Growth Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 cresco labs
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Curaleaf Holdings
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Ecofibre Limited
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 green thumb industries (gti)
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Harvest Health and Recreation
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 HEXO Corp.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Indiva
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Maricann Group Inc.
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Medical Marijuana Inc.
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 MedMen
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Organigrams Holding Inc.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Stenocare
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 2. CANNABIS MARKET SIZE, FOR BUDS OR MARIJUANA FLOWER, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. CANNABIS MARKET FOR BUDS OR MARIJUANA FLOWER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. CANNABIS MARKET SIZE, FOR CANNABIS EXTRACTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. CANNABIS MARKET FOR CANNABIS EXTRACTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 7. CANNABIS MARKET SIZE, FOR THC-DOMINANT, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. CANNABIS MARKET FOR THC-DOMINANT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. CANNABIS MARKET SIZE, FOR BALANCED THC AND CBD, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. CANNABIS MARKET FOR BALANCED THC AND CBD, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. CANNABIS MARKET SIZE, FOR CBD-DOMINANT, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. CANNABIS MARKET FOR CBD-DOMINANT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 14. CANNABIS MARKET SIZE, FOR MEDICAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. CANNABIS MARKET FOR MEDICAL, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. CANNABIS MARKET SIZE, FOR RECREATIONAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. CANNABIS MARKET FOR RECREATIONAL, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. CANNABIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. CANNABIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. CANNABIS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. NORTH AMERICA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 22. NORTH AMERICA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 23. NORTH AMERICA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 24. NORTH AMERICA CANNABIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. U.S. CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 26. U.S. CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 27. U.S. CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 28. CANADA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 29. CANADA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 30. CANADA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 31. MEXICO CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 32. MEXICO CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 33. MEXICO CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 34. EUROPE CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 35. EUROPE CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 36. EUROPE CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 37. EUROPE CANNABIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 38. GERMANY CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 39. GERMANY CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 40. GERMANY CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 41. ITALY CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 42. ITALY CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 43. ITALY CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. DENMARK CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 45. DENMARK CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 46. DENMARK CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 47. POLAND CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 48. POLAND CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 49. POLAND CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 50. UK CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 51. UK CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 52. UK CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 53. REST OF EUROPE CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 54. REST OF EUROPE CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 55. REST OF EUROPE CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 56. ASIA-PACIFIC CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 57. ASIA-PACIFIC CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 58. ASIA-PACIFIC CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 59. ASIA-PACIFIC CANNABIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 60. THAILAND CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 61. THAILAND CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 62. THAILAND CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 63. AUSTRALIA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 64. AUSTRALIA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 65. AUSTRALIA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. NEW ZEALAND CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 67. NEW ZEALAND CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 68. NEW ZEALAND CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 70. REST OF ASIA-PACIFIC CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 72. LAMEA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 73. LAMEA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 74. LAMEA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 75. LAMEA CANNABIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 76. BRAZIL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 77. BRAZIL CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 78. BRAZIL CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 79. SOUTH AFRICA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 80. SOUTH AFRICA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 81. SOUTH AFRICA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 82. REST OF LAMEA CANNABIS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 83. REST OF LAMEA CANNABIS MARKET, BY COMPOUND, 2021-2031 ($MILLION)
- TABLE 84. REST OF LAMEA CANNABIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 85.AURORA CANNABIS INC.: COMPANY SNAPSHOT
- TABLE 86.AURORA CANNABIS INC.: OPERATING SEGMENTS
- TABLE 87.AURORA CANNABIS INC.: PRODUCT PORTFOLIO
- TABLE 88.AURORA CANNABIS INC.: NET SALES,
- TABLE 89.AURORA CANNABIS INC.: KEY STRATERGIES
- TABLE 90.APHRIA INC.: COMPANY SNAPSHOT
- TABLE 91.APHRIA INC.: OPERATING SEGMENTS
- TABLE 92.APHRIA INC.: PRODUCT PORTFOLIO
- TABLE 93.APHRIA INC.: NET SALES,
- TABLE 94.APHRIA INC.: KEY STRATERGIES
- TABLE 95.CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
- TABLE 96.CANOPY GROWTH CORPORATION: OPERATING SEGMENTS
- TABLE 97.CANOPY GROWTH CORPORATION: PRODUCT PORTFOLIO
- TABLE 98.CANOPY GROWTH CORPORATION: NET SALES,
- TABLE 99.CANOPY GROWTH CORPORATION: KEY STRATERGIES
- TABLE 100.CRESCO LABS: COMPANY SNAPSHOT
- TABLE 101.CRESCO LABS: OPERATING SEGMENTS
- TABLE 102.CRESCO LABS: PRODUCT PORTFOLIO
- TABLE 103.CRESCO LABS: NET SALES,
- TABLE 104.CRESCO LABS: KEY STRATERGIES
- TABLE 105.CURALEAF HOLDINGS: COMPANY SNAPSHOT
- TABLE 106.CURALEAF HOLDINGS: OPERATING SEGMENTS
- TABLE 107.CURALEAF HOLDINGS: PRODUCT PORTFOLIO
- TABLE 108.CURALEAF HOLDINGS: NET SALES,
- TABLE 109.CURALEAF HOLDINGS: KEY STRATERGIES
- TABLE 110.ECOFIBRE LIMITED: COMPANY SNAPSHOT
- TABLE 111.ECOFIBRE LIMITED: OPERATING SEGMENTS
- TABLE 112.ECOFIBRE LIMITED: PRODUCT PORTFOLIO
- TABLE 113.ECOFIBRE LIMITED: NET SALES,
- TABLE 114.ECOFIBRE LIMITED: KEY STRATERGIES
- TABLE 115.GREEN THUMB INDUSTRIES (GTI): COMPANY SNAPSHOT
- TABLE 116.GREEN THUMB INDUSTRIES (GTI): OPERATING SEGMENTS
- TABLE 117.GREEN THUMB INDUSTRIES (GTI): PRODUCT PORTFOLIO
- TABLE 118.GREEN THUMB INDUSTRIES (GTI): NET SALES,
- TABLE 119.GREEN THUMB INDUSTRIES (GTI): KEY STRATERGIES
- TABLE 120.HARVEST HEALTH AND RECREATION: COMPANY SNAPSHOT
- TABLE 121.HARVEST HEALTH AND RECREATION: OPERATING SEGMENTS
- TABLE 122.HARVEST HEALTH AND RECREATION: PRODUCT PORTFOLIO
- TABLE 123.HARVEST HEALTH AND RECREATION: NET SALES,
- TABLE 124.HARVEST HEALTH AND RECREATION: KEY STRATERGIES
- TABLE 125.HEXO CORP.: COMPANY SNAPSHOT
- TABLE 126.HEXO CORP.: OPERATING SEGMENTS
- TABLE 127.HEXO CORP.: PRODUCT PORTFOLIO
- TABLE 128.HEXO CORP.: NET SALES,
- TABLE 129.HEXO CORP.: KEY STRATERGIES
- TABLE 130.INDIVA: COMPANY SNAPSHOT
- TABLE 131.INDIVA: OPERATING SEGMENTS
- TABLE 132.INDIVA: PRODUCT PORTFOLIO
- TABLE 133.INDIVA: NET SALES,
- TABLE 134.INDIVA: KEY STRATERGIES
- TABLE 135.MARICANN GROUP INC.: COMPANY SNAPSHOT
- TABLE 136.MARICANN GROUP INC.: OPERATING SEGMENTS
- TABLE 137.MARICANN GROUP INC.: PRODUCT PORTFOLIO
- TABLE 138.MARICANN GROUP INC.: NET SALES,
- TABLE 139.MARICANN GROUP INC.: KEY STRATERGIES
- TABLE 140.MEDICAL MARIJUANA INC.: COMPANY SNAPSHOT
- TABLE 141.MEDICAL MARIJUANA INC.: OPERATING SEGMENTS
- TABLE 142.MEDICAL MARIJUANA INC.: PRODUCT PORTFOLIO
- TABLE 143.MEDICAL MARIJUANA INC.: NET SALES,
- TABLE 144.MEDICAL MARIJUANA INC.: KEY STRATERGIES
- TABLE 145.MEDMEN: COMPANY SNAPSHOT
- TABLE 146.MEDMEN: OPERATING SEGMENTS
- TABLE 147.MEDMEN: PRODUCT PORTFOLIO
- TABLE 148.MEDMEN: NET SALES,
- TABLE 149.MEDMEN: KEY STRATERGIES
- TABLE 150.ORGANIGRAMS HOLDING INC.: COMPANY SNAPSHOT
- TABLE 151.ORGANIGRAMS HOLDING INC.: OPERATING SEGMENTS
- TABLE 152.ORGANIGRAMS HOLDING INC.: PRODUCT PORTFOLIO
- TABLE 153.ORGANIGRAMS HOLDING INC.: NET SALES,
- TABLE 154.ORGANIGRAMS HOLDING INC.: KEY STRATERGIES
- TABLE 155.STENOCARE: COMPANY SNAPSHOT
- TABLE 156.STENOCARE: OPERATING SEGMENTS
- TABLE 157.STENOCARE: PRODUCT PORTFOLIO
- TABLE 158.STENOCARE: NET SALES,
- TABLE 159.STENOCARE: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.CANNABIS MARKET SEGMENTATION
- FIGURE 2.CANNABIS MARKET,2021-2031
- FIGURE 3.CANNABIS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.CANNABIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.VALUE CHAIN ANALYSIS
- FIGURE 13.MARKET SHARE ANALYSIS
- FIGURE 14.CANNABIS MARKET,BY PRODUCT TYPE,2021(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF BUDS OR MARIJUANA FLOWER CANNABIS MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CANNABIS EXTRACTS CANNABIS MARKET,2021-2031(%)
- FIGURE 17.CANNABIS MARKET,BY COMPOUND,2021(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF THC-DOMINANT CANNABIS MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF BALANCED THC AND CBD CANNABIS MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CBD-DOMINANT CANNABIS MARKET,2021-2031(%)
- FIGURE 21.CANNABIS MARKET,BY APPLICATION,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MEDICAL CANNABIS MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF RECREATIONAL CANNABIS MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS CANNABIS MARKET,2021-2031(%)
- FIGURE 25.CANNABIS MARKET BY REGION,2021
- FIGURE 26.U.S. CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 30.ITALY CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 31.DENMARK CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 32.POLAND CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 33.UK CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 35.THAILAND CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 36.AUSTRALIA CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 37.NEW ZEALAND CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 38.REST OF ASIA-PACIFIC CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 39.BRAZIL CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 40.SOUTH AFRICA CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 41.REST OF LAMEA CANNABIS MARKET,2021-2031($MILLION)
- FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 46.COMPETITIVE DASHBOARD
- FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 48.AURORA CANNABIS INC..: NET SALES ,($MILLION)
- FIGURE 49.APHRIA INC..: NET SALES ,($MILLION)
- FIGURE 50.CANOPY GROWTH CORPORATION.: NET SALES ,($MILLION)
- FIGURE 51.CRESCO LABS.: NET SALES ,($MILLION)
- FIGURE 52.CURALEAF HOLDINGS.: NET SALES ,($MILLION)
- FIGURE 53.ECOFIBRE LIMITED.: NET SALES ,($MILLION)
- FIGURE 54.GREEN THUMB INDUSTRIES (GTI).: NET SALES ,($MILLION)
- FIGURE 55.HARVEST HEALTH AND RECREATION.: NET SALES ,($MILLION)
- FIGURE 56.HEXO CORP..: NET SALES ,($MILLION)
- FIGURE 57.INDIVA.: NET SALES ,($MILLION)
- FIGURE 58.MARICANN GROUP INC..: NET SALES ,($MILLION)
- FIGURE 59.MEDICAL MARIJUANA INC..: NET SALES ,($MILLION)
- FIGURE 60.MEDMEN.: NET SALES ,($MILLION)
- FIGURE 61.ORGANIGRAMS HOLDING INC..: NET SALES ,($MILLION)
- FIGURE 62.STENOCARE.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook